Proteovant Therapeutics
Jonggil Choi serves as VP of Bioinvestment Center, SK Inc. He leads value-up strategies in next-generation bio initiatives of the 2nd largest conglomerate in South Korea, he oversees inorganic opportunities including M&A and investments of SK Group. Mr. Choi has 20+ years of experience in the Pharma Biz. He started his carrier as a researcher at Group’s subsidiary, SK Biopharm, and extended his carrier as a corporate strategy developer. He holds a M.S. in Biochemical Engineering and a B.S. in Life Science from the Korea Advanced Institute of Science and Technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Proteovant Therapeutics
Proteovant Therapeutics is a biotechnology company that utilizes protein degradation research in the development of medicines for diseases.